Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Myasthenia Gravis × Pyridostigmine Bromide × Clear all

Phase

Status

Unknown 4 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1 Autoimmune Diseases 1

Interventions

telitacicept 3 rozanolixizumab 2 Prednisone 2 ravulizumab 1 fludarabine 1 blinatumomab 1 Pyridostigmine Bromide 1 Psychodrama 1 Prednisolone 1 Population Groups 1 Cyclophosphamide 1 Art Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06723548 2024-12-09

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

First Affiliated Hospital of Wenzhou Medical University

Phase 4 Not yet recruiting

Autoimmune Diseases, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡